Screener
Nurix Therapeutics, Inc. NRIX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| Total operating expenses | 103,247 | 92,378 | 201,994 | 173,695 |
| Loss from operations | (94,204) | (48,322) | (186,699) | (111,186) |
| Interest and other income, net | 4,398 | 5,618 | 9,719 | 12,131 |
| Loss before income taxes | (89,806) | (42,704) | (176,980) | (99,055) |
| Provision for (benefit from) income taxes | (271) | 760 | (271) | 760 |
| Net loss | $(89,535) | $(43,464) | $(176,709) | $(99,815) |
| Net loss per share, basic and diluted | $(0.81) | $(0.52) | $(1.60) | $(1.19) |
| Weighted-average number of shares outstanding, basic and diluted | 111,084,423 | 83,882,477 | 110,583,610 | 83,723,403 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s EPS (diluted)?
- Nurix Therapeutics, Inc. (NRIX) reported EPS (diluted) of -$0.81 in Q1 2026.
- How has Nurix Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Nurix Therapeutics, Inc.'s EPS (diluted) decreased by 55.8% year-over-year, from -$0.52 to -$0.81.
- What is the long-term trend for Nurix Therapeutics, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s EPS (diluted) has grown at a 2.8% compound annual growth rate (CAGR), from -$2.73 to -$3.05.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Nurix Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude